MGDI

MGD Innovations, LLC

Application Filed: 2019-03-18
Trademark Application Details
Trademark Logo MGDI

Mark For: MGDI™ trademark registration is intended to cover the categories of medical devices, namely, devices for analyzing, diagnosing, treating and monitoring dry eye and meibomian gland dysfunction; Medical devices, namely, devices for relieving and expressing obstructions or occlusions from meibomian glands being medical devices for use in treating meibomian gland dysfunction (MGD); Medical devices, namely, devices for injecting and removing medications, pharmaceuticals, blood derived products, biologics, stem cells, and medicaments into and from meibomian glands being medical devices for use in treating meibomian gland dysfunction (MGD); Medical devices for placing and implanting stents into the intraductal gland space being medical devices for use in treating meibomian gland dysfunction (MGD); medical devices for implanting whole or partial glands 3D printed or otherwise obtained such as organ culture being medical devices for use in treating meibomian gland dysfunction (MGD). [all]

Status

2020-07-13 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88344375
Mark Literal ElementsMGDI
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK. SERVICE MARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2019-09-24
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 026: Measuring and Scientific Appliances
  • 039: Clothing
  • 044: Dental, Medical and Surgical Appliances
Primary International Class
  • 010 - Primary Class
  • (Medical Apparatus) Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameAllison R. Imber, Esq.
Attorney Docket Number0130601
Law Office AssignedO10
Employee NameBURCH, JILLIAN RENEE

Timeline

2019-03-18Application Filed
2019-07-30Published
2019-07-30Published for Opposition
2019-09-24Location: INTENT TO USE SECTION
2019-09-24Status: Live/Pending
2020-01-07Transaction Date
2020-02-25Status: A first request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: MGD Innovations, LLC
Address3001 Swann Avenue Tampa, FLORIDA UNITED STATES 33609
Legal Entity TypeLimited Liability Company
Legal Entity StateFLORIDA

Documents

DrawingJPEG2019-03-18
TEAS RF New ApplicationMULTI2019-03-18
XSearch Search SummaryXML2019-05-29
Notation to FileXML2019-06-04
Examiners AmendmentXML2019-06-05
Notation to FileAPPLICATION/XML2019-06-05
Amendment and Mail Process CompleteMULTI2019-06-06
TRAM Snapshot of App at Pub for OppostnAPPLICATION/XML,IMAGE/JPEG2019-06-11
Notice of PublicationXML2019-07-10
Notification Of Notice of PublicationXML2019-07-10
OG Publication ConfirmationAPPLICATION/XML2019-07-30
Notice of AllowanceXML2019-09-24
Extension of Time to File SOUXML2020-02-25
ITU Extension ApprovalXML2020-02-27
ITU Unit ActionMULTI2020-02-27

Attorney of Record

ALLISON R. IMBER, ESQ.
ALLEN, DYER, DOPPELT & GILCHRIST, PA
255 SOUTH ORANGE AVENUE, SUITE 1401
ORLANDO, FL 32801

Good, Services, and Codes


IC 010. US 026 039 044. G & S: Medical devices, namely, devices for analyzing, diagnosing, treating and monitoring dry eye and meibomian gland dysfunction; Medical devices, namely, devices for relieving and expressing obstructions or occlusions from meibomian glands being medical devices for use in treating meibomian gland dysfunction (MGD); Medical devices, namely, devices for injecting and removing medications, pharmaceuticals, blood derived products, biologics, stem cells, and medicaments into and from meibomian glands being medical devices for use in treating meibomian gland dysfunction (MGD); Medical devices for placing and implanting stents into the intraductal gland space being medical devices for use in treating meibomian gland dysfunction (MGD); medical devices for implanting whole or partial glands 3D printed or otherwise obtained such as organ culture being medical devices for use in treating meibomian gland dysfunction (MGD)
IC 041. US 100 101 107. G & S: Educational services, namely, conducting presentations, lectures, classes, seminars and workshops in the fields of ophthalmology, meibomian glands, dry eye and eye disease for the purpose of monitoring, analyzing, diagnosing and treatment and distribution of course and educational materials in connection therewith; providing a website featuring non-downloadable videos in the field of meibomian gland dysfunction and dry eye treatment

International Codes:10
U.S. Codes:026,039,044
International Codes:41
U.S. Codes:100,101,107
Type CodeType
GS0101Medical devices, namely, devices for analyzing, diagnosing, treating and monitoring dry eye and meibomian gland dysfunction; Medical devices, namely, devices for relieving and expressing obstructions or occlusions from meibomian glands being medical devices for use in treating meibomian gland dysfunction (MGD); Medical devices, namely, devices for injecting and removing medications, pharmaceuticals, blood derived products, biologics, stem cells, and medicaments into and from meibomian glands being medical devices for use in treating meibomian gland dysfunction (MGD); Medical devices for placing and implanting stents into the intraductal gland space being medical devices for use in treating meibomian gland dysfunction (MGD); medical devices for implanting whole or partial glands 3D printed or otherwise obtained such as organ culture being medical devices for use in treating meibomian gland dysfunction (MGD)
GS0411Educational services, namely, conducting presentations, lectures, classes, seminars and workshops in the fields of ophthalmology, meibomian glands, dry eye and eye disease for the purpose of monitoring, analyzing, diagnosing and treatment and distribution of course and educational materials in connection therewith; providing a website featuring non-downloadable videos in the field of meibomian gland dysfunction and dry eye treatment

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-02-27
TEAS EXTENSION RECEIVED2020-02-25
EXTENSION 1 GRANTED2020-02-2598765
EXTENSION 1 FILED2020-02-2598765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2019-09-24
PUBLISHED FOR OPPOSITION2019-07-30
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-07-30
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-07-10
ASSIGNED TO LIE2019-06-2176568
APPROVED FOR PUB - PRINCIPAL REGISTER2019-06-10
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2019-06-056328
EXAMINERS AMENDMENT E-MAILED2019-06-056328
EXAMINERS AMENDMENT -WRITTEN2019-06-0594494
EXAMINER'S AMENDMENT ENTERED2019-06-0588888
ASSIGNED TO EXAMINER2019-05-2994494
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-04-05
NEW APPLICATION ENTERED IN TRAM2019-03-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed